Variational Mixture of Graph Neural Experts for Alzheimer's Disease Biomarker Recognition in EEG Brain Networks
By: Jun-En Ding , Anna Zilverstand , Shihao Yang and more
Potential Business Impact:
Helps doctors tell different brain diseases apart.
Dementia disorders such as Alzheimer's disease (AD) and frontotemporal dementia (FTD) exhibit overlapping electrophysiological signatures in EEG that challenge accurate diagnosis. Existing EEG-based methods are limited by full-band frequency analysis that hinders precise differentiation of dementia subtypes and severity stages. We propose a variational mixture of graph neural experts (VMoGE) that integrates frequency-specific biomarker identification with structured variational inference for enhanced dementia diagnosis and staging. VMoGE employs a multi-granularity transformer to extract multi-scale temporal patterns across four frequency bands, followed by a variational graph convolutional encoder using Gaussian Markov Random Field priors. Through structured variational inference and adaptive gating, VMoGE links neural specialization to physiologically meaningful EEG frequency bands. Evaluated on two diverse datasets for both subtype classification and severity staging, VMoGE achieves superior performance with AUC improvements of +4% to +10% over state-of-the-art methods. Moreover, VMoGE provides interpretable insights through expert weights that correlate with clinical indicators and spatial patterns aligned with neuropathological signatures, facilitating EEG biomarker discovery for comprehensive dementia diagnosis and monitoring.
Similar Papers
Flexible and Explainable Graph Analysis for EEG-based Alzheimer's Disease Classification
Machine Learning (CS)
Finds Alzheimer's early using brain wave patterns.
An explainable framework for the relationship between dementia and glucose metabolism patterns
Machine Learning (CS)
Finds brain changes linked to memory loss.
Higher-Order Domain Generalization in Magnetic Resonance-Based Assessment of Alzheimer's Disease
CV and Pattern Recognition
Helps doctors find Alzheimer's better everywhere.